Inappropriate Use of DPP-4 Inhibitors

descriptionPublicationkeyboard_double_arrow_right Conference object 01 Jan 2014Embargo end date: 18 Nov 2014 English Publisher:German Medical Science GMS Publishing House; Düsseldorf

Authors: Reichel, A; Blank, S; Tamminga, M; Schoch, GG; Steimle, T;

doi: 10.3205/14gaa20

Inappropriate Use of DPP-4 Inhibitors

- Summary
- Subjects
- Metrics

Abstract

Background: Dipeptidyl peptidase-4 (DPP-4) inhibitors are a newer class of oral anti-hyperglycemic agents for the treatment of type 2 diabetes. They have shown reduction of blood glucose, but potential impact on cardiovascular outcomes and long-term safety remain inconclusive. For that reasons DPP-4[for full text, please go to the a.m. URL]

21. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie, 9. Deutscher Pharmakovigilanztag

Keywords

ddc: 610, 610 Medical sciences; Medicine

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average